Skip to main content

Table 8 Studies evaluating maternal alcohol consumption as a determinant of maternal or neonatal PFAS concentrations by PFAS, study design, and findings

From: Determinants of maternal and neonatal PFAS concentrations: a review

PFAS (study design) a

N

Positive findings

N

Negative findings

N

Null findings

Legacy PFAS

 PFOA

2

[91, 93]

–

–

6

[64, 66, 67, 74, 81, 82]

 PFOS

1

[91]

–

–

7

[64, 66, 67, 74, 81, 82, 93]

 PFNA

2

[91, 93]

–

–

5

[64, 66, 74, 81, 82]

 PFHxS

1

[91]

–

–

5

[66, 74, 81, 82, 93]

Other PFAS

 NMeFOSAA

–

–

–

–

1

[74]

 PFDeA

1

[93]

–

–

2

[74, 82]

 PFDoA

–

–

–

–

1

[82]

 PFHpS

1

[93]

–

–

–

–

 PFPeA

–

–

–

–

1

[74]

 PFTrDA

–

–

–

–

1

[82]

 PFUnDA

1

[93]

–

–

3

[64, 74, 82]

  1. a C/L Cohort/longitudinal studies, C-S Cross-sectional studies, PFOA Perfluorooctanoic acid; PFOS: Perfluorooctane sulfonic acid, PFNA Perfluorononanoic acid, PFHxS Perfluorohexane sulfonate, NMeFOSAA: N-methyl perfluorooctanesulfonamidoacetic acid, PFDeA Perfluorodecanoic acid, PFDoA Perfluorododecanoic acid, PFHpS Perfluoroheptanesulfonic acid, PFPeA Perfluoropentanoic acid, PFTrDA Perfluorotridecanoic acid, PFUnDA Perfluoroundecanoic acid